zdorПроблемы здоровья и экологииHealth and Ecology Issues2220-09672708-6011Gomel State Medical University10.51523/2708-6011.2024-21-2-01zdor-2347Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESРецидивирующий бактериальный вагинозRecurrent bacterial vaginosishttps://orcid.org/0000-0003-4893-3865ПятковаН. П.PyatkovaN. P.

Пяткова Наталья Петровна, ассистент кафедры акушерства и гинекологии с курсом ФПКиП 

г. Гомель

Natalia P. Pyatkova, Assistant Lecturer at the Department of Obstetrics and Gynecology with the course of Advanced Training and Retraining

Gomel

pyatkovanatasha635@mail.ruГомельский государственный медицинский университетGomel State Medical University202427052024212714Copyright © Пяткова Н.П., 20242024Пяткова Н.П.Pyatkova N.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.gsmu.by/jour/article/view/2347

Актуальность проблемы рецидивирующей урогенитальной инфекции определяется ее высокой распространенностью в структуре гинекологической заболеваемости. В настоящее время продолжает увеличиваться доля заболеваний нижнего отдела полового тракта, связанных с количественным дисбалансом условно-патогенных микроорганизмов влагалища бактериальной природы.

Автором проведена систематизация концептуально новых знаний о патогенетических особенностях бактериального вагиноза (БВ) у женщин репродуктивного возраста, актуальных методах клинико-лабораторной диагностики рецидивирующего бактериального вагиноза (РБВ) и современных тенденциях его лечения, предложенных как отечественными, так и зарубежными специалистами, и применяемых с целью профилактики осложнений и рецидивирования.

The relevance of the problem of recurrent urogenital infection is determined by its highest prevalence in the structure of gynecological morbidity. At present, the proportion of diseases of the lower genital tract associated with a quantitative imbalance of opportunistic pathogens of the vagina of a bacterial nature continues to increase.

The author systematized conceptually new knowledge on pathogenetic features of bacterial vaginosis in women of reproductive age, current methods of clinical and laboratory diagnosis of recurrent bacterial vaginosis, modern effective methods for the treatment, proposed by both domestic and foreign experts and used to prevent complications and prevent recurrence.

вагинальная инфекциядисбиоз влагалищарецидивирующий бактериальный вагинознарушение микрофлорыvaginal infectionvaginal dysbiosisrecurrent bacterial vaginosismicroflora disordersReferencesДикке Г.Б. Бактериальный вагиноз: новые аспекты этиопатогенеза и выбора терапевтических стратегий. РМЖ. Мать и дитя. 2019;2(4):307-313. DOI: https://doi.org/10.32364/2618-8430-2019-2-4-307-313Dikke GB. Bacterial vaginosis: new aspects of etiopathogenesis and choice of therapeutic strategies. RMZh. Mat’ i ditya. 2019;2(4):307-13. DOI: https://doi.org/10.32364/2618-8430-2019-2-4-307-313Балан В.Е., Тихомирова Е.В., Овчинникова В.В. Рецидивирующий бактериальный вагиноз: возможность увеличения продолжительности ремиссии. Акушерство и гинекология. 2017;(1):83-86. DOI: https://dx.doi.org/10.18565/aig.2017.1.83-8Balan VE, Tikhomirova EV, Ovchinnikova VV. Recurrent bacterial vaginosis: the possibility of increasing the duration of remission. Akusherstvo i ginekologiya. 2017;(1):83-86. DOI: https://dx.doi.org/10.18565/aig.2017.1.83-8Ryckman KK. Predicting risk of bacterial vaginosis: The role of race, smoking and corticotropin-releasing hormonerelated genes. Mol. Hum. Reprod. 2009;15:31-37. DOI: https://dx.doi.org/10.1093/molehr/gan081Ryckman KK. Predicting risk of bacterial vaginosis: The role of race, smoking and corticotropin-releasing hormonerelated genes. Mol. Hum. Reprod. 2009;15:31-37. DOI: https://dx.doi.org/10.1093/molehr/gan081Савичева А.М., Тапильская Н.И., Шипицына Е.В., Воробьева Н.Е. Бактериальный вагиноз и аэробный вагинит как основные нарушения баланса вагинальной микрофлоры. Особенности диагностики и терапии. Акушерство и гинекология. 2017;(5):24-31. DOI: https://dx.doi.org/10.18565/aig.2017.5.24-31Savicheva AM, Tapil’skaya NI, Shipicyna EV, Vorob’yova NE. Bacterial vaginosis and aerobic vaginitis as the main imbalance of vaginal microflora. Features of diagnosis and therapy. Akusherstvo i ginekologiya. 2017;(5):24-31. DOI: https://dx.doi.org/10.18565/aig.2017.5.24-31Марушкина О.И. Терапия бактериального вагиноза у небеременных пациенток. Медицинский совет. 2019;(7):104-109. DOI: https://doi.org/10.21518/2079-701X-2019-7-104-109Marushkina OI. Treatment of bacterial vaginosis in non-pregnant patients. Medicinskij sovet. 2019;(7):104-109. DOI: https://doi.org/10.21518/2079-701X-2019-7-104-109Marrazzo JM, Fiedler TL, Srinivasan S. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J. Infect. Dis. 2012;205(10):1580-1588. DOI: https://doi.org/10.1093/infdis/jis242Swidsinski A, Doerffel Y, Loening-Baucke V. Gardnerella biofilm involves females and males and is transmit-ted sexually. Gynecol. Obstet. Invest. 2010;70(4):256-263. DOI: https://doi.org/10.1159/000314015Schwebke JR, Muzny CA, Josey WE. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J. Infect. Dis. 2014;210(3):338-343. DOI: https://doi.org/10.1093/infdis/jiu089Marrazzo JM, Fiedler TL, Srinivasan S. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J. Infect. Dis. 2012;205(10):1580-1588. DOI: https://doi.org/10.1093/infdis/jis242Крысанова АА. Gardnerella vaginalis: генотипическое и фенотипическое разнообразие, факторы вирулентности и роль в патогенезе бактериального вагиноз. Журнал акушерства и женских болезней. 2019;68(1):59-68. DOI: http://dx.doi.org/10.17816/JOWD68159-68Schwebke JR, Muzny CA, Josey WE. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J. Infect. Dis. 2014;210(3):338-343. DOI: https://doi.org/10.1093/infdis/jiu089Patterson JL, Stull-Lane А, Girerd PH, Jefferson KK. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology. 2010;156:392-399. DOI: https://doi.org/10.1099/mic.0.034280-0Krysanova AA. Gardnerella vaginalis: генотипическое и фенотипическое разнообразие, факторы вирулентности и роль в патогенезе бактериального вагиноз. Zhurnal akusherstva i zhenskikh bolezney. 2019;68(1):59-68. DOI: http://dx.doi.org/10.17816/JOWD68159-68Larsen JM. The Immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151 (4):363-374. DOI: https://doi.org/10.1111/imm.12760Patterson JL, Stull-Lane А, Girerd PH, Jefferson KK. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology. 2010;156:392-399. DOI: https://doi.org/10.1099/mic.0.034280-0Bunyan IA, Gatea AK, Hameed AK. Molecular Identification and Genotyping of Atopobium vaginae, 16S rRNA Gene from Bacterial Vaginosis Miscarriage Women in Al-Hillah City. IJPQA. 2020; 24 (1): 124-130. DOI: http://dx.doi.org/10.25258/ijpqa.11.1.19Larsen JM. The Immune response to Prevotella bacteria in chronic inflammatory disease. Immunology. 2017;151 (4):363-374. DOI: https://doi.org/10.1111/imm.12760Hardy L, Jespers V, Dahchour N, Mwambarangwe L, Musengamana V, Vaneechoutte M, Crucitti T. Unravelling the bacterial vaginosis-associated biofilm: a multiplex Gardnerella vaginalis and Atopobium vaginae fluorescence in situ hybridization assay using peptide nucleic acid probes. PLoS ONE. 2015;10 (8):e0136658. DOI: http://dx.doi.org/10.1371/journal.pone.0136658Bunyan IA, Gatea AK, Hameed AK. Molecular Identification and Genotyping of Atopobium vaginae, 16S rRNA Gene from Bacterial Vaginosis Miscarriage Women in Al-Hillah City. IJPQA. 2020; 24 (1): 124-130. DOI: http://dx.doi.org/10.25258/ijpqa.11.1.19Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 1991;29(2):297-301. DOI: http://dx.doi.org/10.1128/jcm.29.2.297-301.1991Hardy L, Jespers V, Dahchour N, Mwambarangwe L, Musengamana V, Vaneechoutte M, Crucitti T. Unravelling the bacterial vaginosis-associated biofilm: a multiplex Gardnerella vaginalis and Atopobium vaginae fluorescence in situ hybridization assay using peptide nucleic acid probes. PLoS ONE. 2015;10 (8):e0136658. DOI: http://dx.doi.org/10.1371/journal.pone.0136658Menard JP, Mazouni C, Fenollar F, Raoult D, Boubli L, Bretelle F. Diagnostic accuracy of quantitative real-time PCR assay versus clinical and Gram stain identification of bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2010;29(12):1547-1552. DOI: https://doi.org/10.1007/s10096-010-1039-3Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 1991;29(2):297-301. DOI: http://dx.doi.org/10.1128/jcm.29.2.297-301.1991Nyirjesy P, McIntosh MJ, Gattermeir DJ, Schumacher RJ, Steinmetz JI, Joffrion JL. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis. Am. J. Obstet. Gynecol. 2006;194(5):1277-1282. DOI: https://doi.org/10.1016/j.ajog.2005.11.006Menard JP, Mazouni C, Fenollar F, Raoult D, Boubli L, Bretelle F. Diagnostic accuracy of quantitative real-time PCR assay versus clinical and Gram stain identification of bacterial vaginosis. Eur J Clin Microbiol Infect Dis. 2010;29(12):1547-1552. DOI: https://doi.org/10.1007/s10096-010-1039-3Petrina MA, Cosentino LA; Rabe LK, Hillier SL. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe. 2017;47:115-119. DOI: https://doi.org/10.1016/j.anaerobe.2017.05.005Nyirjesy P, McIntosh MJ, Gattermeir DJ, Schumacher RJ, Steinmetz JI, Joffrion JL. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis. Am. J. Obstet. Gynecol. 2006;194(5):1277-1282. DOI: https://doi.org/10.1016/j.ajog.2005.11.006Летяева О.И. Бактериальный вагиноз: современные возможности и перспективы длительного контроля. Российский вестник акушера-гинеколога. 2019;19(2):100-104. DOI: https://doi.org/10.17116/rosakush201919021100Petrina MA, Cosentino LA; Rabe LK, Hillier SL. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe. 2017;47:115-119. DOI: https://doi.org/10.1016/j.anaerobe.2017.05.005Малова И.О., Афанасьева И.Г. Бактериальный вагиноз: есть ли альтернатива традиционным препаратам? Медицинский совет. 2019;(7):93-103. DOI: https://doi.org/10.21518/2079-701X-2019-7-93-103Letyatva OI. Bacterial vaginosis: modern possibilities and prospects for long-term control. Rossijskij vestnik akushera-ginekologa. 2019;19(2):100-104. DOI: https://doi.org/10.17116/rosakush201919021100Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, Strahilevitz J, Moses AE, Shapiro H, Yagel S, Elinav E. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nature Medicine. 2019;25:1500-1504. DOI: https://doi.org/10.1038/s41591-019-0600-6Malova IO, Afanas’eva IG. Бактериальный вагиноз: есть ли альтернатива традиционным препаратам? Medicinskij sovet. 2019;(7):93-103. DOI: https://doi.org/10.21518/2079-701X-2019-7-93-103Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, Strahilevitz J, Moses AE, Shapiro H, Yagel S, Elinav E. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nature Medicine. 2019;25:1500-1504. DOI: https://doi.org/10.1038/s41591-019-0600-6Lev-Sagie A, Goldman-Wohl D, Cohen Y, Dori-Bachash M, Leshem A, Mor U, Strahilevitz J, Moses AE, Shapiro H, Yagel S, Elinav E. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nature Medicine. 2019;25:1500-1504. DOI: https://doi.org/10.1038/s41591-019-0600-6

The authors declare that there are no conflicts of interest present.